VOLTAN, Rebecca
 Distribuzione geografica
Continente #
NA - Nord America 7.971
AS - Asia 4.072
EU - Europa 2.892
SA - Sud America 691
Continente sconosciuto - Info sul continente non disponibili 217
AF - Africa 103
OC - Oceania 8
Totale 15.954
Nazione #
US - Stati Uniti d'America 7.781
SG - Singapore 1.491
IT - Italia 1.031
CN - Cina 969
BR - Brasile 537
VN - Vietnam 500
DE - Germania 389
HK - Hong Kong 315
PL - Polonia 290
UA - Ucraina 239
GB - Regno Unito 225
TR - Turchia 204
FI - Finlandia 154
BD - Bangladesh 150
FR - Francia 120
SE - Svezia 105
JP - Giappone 104
CA - Canada 100
RU - Federazione Russa 92
IN - India 77
ID - Indonesia 74
NL - Olanda 71
AR - Argentina 62
MX - Messico 54
ZA - Sudafrica 41
ES - Italia 29
IQ - Iraq 28
PK - Pakistan 26
CZ - Repubblica Ceca 23
EC - Ecuador 20
LT - Lituania 20
CO - Colombia 19
BE - Belgio 17
CL - Cile 15
UZ - Uzbekistan 15
VE - Venezuela 14
EE - Estonia 13
TN - Tunisia 13
AT - Austria 11
IE - Irlanda 10
KR - Corea 10
MY - Malesia 10
AE - Emirati Arabi Uniti 9
CR - Costa Rica 9
DZ - Algeria 9
KE - Kenya 9
RO - Romania 9
SA - Arabia Saudita 9
MA - Marocco 8
PY - Paraguay 8
AU - Australia 7
AZ - Azerbaigian 7
CH - Svizzera 7
JM - Giamaica 7
PH - Filippine 7
TW - Taiwan 7
AL - Albania 6
CY - Cipro 6
IL - Israele 6
IR - Iran 6
JO - Giordania 6
PE - Perù 6
BO - Bolivia 5
EG - Egitto 5
KG - Kirghizistan 5
UY - Uruguay 5
ET - Etiopia 4
LB - Libano 4
NI - Nicaragua 4
OM - Oman 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
BG - Bulgaria 3
GE - Georgia 3
GR - Grecia 3
MD - Moldavia 3
NG - Nigeria 3
NP - Nepal 3
PT - Portogallo 3
RS - Serbia 3
TT - Trinidad e Tobago 3
TZ - Tanzania 3
BB - Barbados 2
DK - Danimarca 2
HN - Honduras 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LV - Lettonia 2
LY - Libia 2
PS - Palestinian Territory 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AM - Armenia 1
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
BZ - Belize 1
Totale 15.718
Città #
Ashburn 957
Singapore 931
Fairfield 722
Woodbridge 604
San Jose 546
Houston 406
Beijing 352
Ferrara 312
Hong Kong 307
Santa Clara 305
Chandler 304
Seattle 292
Warsaw 282
Ann Arbor 279
Jacksonville 269
Cambridge 268
Dallas 266
Wilmington 247
Council Bluffs 197
Ho Chi Minh City 156
Los Angeles 153
New York 145
Munich 123
Hanoi 116
Milan 114
Tokyo 95
Izmir 89
Nanjing 82
Boardman 73
Lauterbourg 71
Bologna 66
Princeton 61
Jakarta 58
Helsinki 54
São Paulo 52
Shanghai 50
San Diego 49
Turku 47
Rome 42
London 41
Orem 41
Buffalo 38
Chicago 35
Brooklyn 33
Mexico City 30
Poplar 30
Toronto 30
Denver 29
Dong Ket 29
Johannesburg 29
Montreal 28
Da Nang 27
Falls Church 27
Frankfurt am Main 27
Phoenix 27
The Dalles 27
Boston 25
Bremen 24
Nanchang 23
Istanbul 21
Naples 21
Shenyang 21
Mersin 20
Atlanta 19
Chennai 18
Hebei 18
Haiphong 17
Rio de Janeiro 17
Brussels 16
Dearborn 16
Hefei 16
San Francisco 16
Brno 15
Changsha 15
Manchester 15
Ankara 14
Padua 14
Tashkent 14
Tianjin 14
Washington 14
Norwalk 13
Tallinn 13
Amsterdam 12
Brasília 12
Kunming 12
Moscow 12
Florence 11
Genoa 11
Jiaxing 11
Nuremberg 11
Stockholm 11
Hải Dương 10
New Delhi 10
Ninh Bình 10
Turin 10
Augusta 9
Biên Hòa 9
Guangzhou 9
Mountain View 9
Mumbai 9
Totale 10.707
Nome #
Netter's Introduzione all'imaging 367
Cell cycle block by p53 acrivation reduces SARS-COV-2 release in infected alveolar basal epithelial A549-hACE2 cells 353
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 343
Cell cycle block by p53 activation reduces SARS-CoV-2 release in infected alveolar basal epithelial A549-hACE2 cells 285
Intranasal Administration of Recombinant TRAIL Down-Regulates CXCL-1/KC in an Ovalbumin-Induced Airway Inflammation Murine Model 282
Serum From Advanced Heart Failure Patients Promotes Angiogenic Sprouting and Affects the Notch Pathway in Human Endothelial Cells 282
Expeditious Synthesis and Biological Characterization of Enantio-Enriched (-)-Nutlin-3 276
Anticancer Activity of Aqueous Extracts from Asparagus officinalis L. Byproduct on Breast Cancer Cells 274
MDM2/X inhibitors under clinical evaluation: Perspectives for the management of hematological malignancies and pediatric cancer 271
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 270
Antitumoral activity of Asparagus officinalis extracts against breast cancer 259
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 256
Actively targeted nanocarriers for drug delivery to cancer cells 255
HelixComplex snail mucus exhibits pro-survival, proliferative and pro-migration effects on mammalian fibroblasts 253
Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis 247
Multiple dye-doped NIR-emitting silica nanoparticles for both flow cytometry and in vivo imaging 237
The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: Implications for the design of new vaccination strategies against AIDS 235
Anti-leukemic activity of Dasatinib in both p53 wild-type and p53 mutated B malignant cells 235
Characterization Methods for Nanoparticle–Skin Interactions: An Overview 232
Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1 231
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias 227
Clinical perspectives of TRAIL: Insights into central nervous system disorders 225
Applications of nanoparticles in cancer medicine and beyond: optical and multimodal in vivo imaging, tissue targeting and drug delivery 216
Nanoparticles Loaded with Nutlin-3 Display Cytotoxicity Towards p53(wild-type) JVM-2 But Not Towards p53(mutated) BJAB Leukemic Cells 215
Redox signaling and oxidative stress: Cross talk with TNF-related apoptosis inducing ligand activity 212
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 208
Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice 206
Proper design of silica nanoparticles combines high brightness, lack of cytotoxicity and efficient cell endocytosis 200
Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease 198
Heterogeneity of mesenchymal stromal cells in lymphoproliferative disorders 198
In-vitro anticancer activity of Asparagus officinalis extracts on breast carcinoma 194
SRP-35, a newly identified protein of the skeletal muscle sarcoplasmic reticulum, is a retinol dehydrogenase 181
Enhanced Anti-Melanoma Activity of Nutlin-3a Delivered via Ethosomes: Targeting p53-Mediated Apoptosis in HT144 Cells 177
ACE2 up-regulation by MDM2 inhibition reduces inflammation and monocytes adhesion in HUVEC 176
In Vitro Skin sensitisation analysis by the U-SENS method for new molecules innovative materials and medical devices 175
The gamma-secretase inhibitors enhance the anti-leukemic activity of ibrutinib in B-CLL cells 174
Activation of the p53 pathway induces α-smooth muscle actin expression in both myeloid leukemic cells and normal macrophages 172
Asparagus officinalis L. aqueous extracts mediate cell cycle block and migration inhibition in breast cancer cells 160
Live recombinant vectors for AIDS vaccine development 159
Rhesus macaque resistance to mucosal simian immunodeficiency virus infection is associated with a postentry block in viral replication 157
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets? 157
Enhanced cellular immunity to SIV Gag following co-administration of adenoviruses encoding wild-type or mutant HIV Tat and SIV Gag. 156
Nutlin-3a-loaded ethosomes as an efficient nanodelivery system target p53 in melanoma 155
The oncogene DEK promotes leukemic cell survival and is downregulated by both nutlin-3 and chlorambucil in B-chronic lymphocytic leukemic cells 154
Replicating Ad-recombinants encoding non-myristoylated rather than wild-type HIV Nef elicit enhanced cellular immunity 150
p53 and merlin tumor suppressors: Two of a kind 148
Nutlin-3 Loaded Ethosomes and Transethosomes to Prevent UV-Associated Skin Damage 146
Nutlin-3 differentially modulates miRNA34a and miRNA181 versus miR26a and miR155 in p53 proficient and p53 deficient B chronic lymphocytic leukemia (B-CLL) samples 146
Perspectives of protein kinase C (PKC) inhibitors as anti-cancer agents 145
MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib 143
Activation of PKC-epsilon counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members 143
Effects of Nutlin-3a on endothelial cells in the presence of inflammation 141
Preparation and characterization of innovative protein-coated poly(methylmethacrylate) core-shell nanoparticles for vaccine purposes 135
Cell cycle block by p53 activation reduces SARS-CoV-2 release in A549-hAce2 cells 131
Characterization of immune responses elicited in mice by intranasal co-immunization with HIV-1 Tat, gp140 DeltaV2Env and/or SIV Gag proteins and the nontoxicogenic heat-labile Escherichia coli enterotoxin 130
Characterization of HIV-1 Tat proteins mutated in the transactivation domain for prophylactic and therapeutic application 129
Nutrients, herbal bioactive derivatives and commensal microbiota as tools to lower the risk of SARS-CoV-2 infection 128
DNA prime and protein boost immunization with innovative polymeric cationic core-shell nanoparticles elicits broad immune responses and strongly enhance cellular responses of HIV-1 tat DNA vaccination 128
MDM2 inhibitors counteract inflammation by stabilization of ACE2 in vitro 127
Role of miRNA in adult ocular tumorigenesis 126
Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors 125
Ethosomes nanodelivery of the MDM2 inhibitor Nutlin-3a efficiently induces cells death in melanoma 123
In vitro endothelial cell proliferation assay reveals distinct levels of proangiogenic cytokines characterizing sera of healthy subjects and of patients with heart failure 123
Human Full-Length Osteoprotegerin Induces the Proliferation of Rodent Vascular Smooth Muscle Cells both in vitro and in vivo 121
Endothelial cells obtained from patients affected by chronic venous disease exhibit a pro-inflammatory phenotype. 120
The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia 119
Dasatinib plus Nutlin-3 shows synergistic anti-leukemic activity in both p53wild-type and p53mutated B chronic lymphocytic leukemias by inhibiting the Akt pathway. 117
Nutlin-3 downregulates the expression of the Oncogene TCL1 in primary B Chronic Lymphocytic Leukemic cells. 116
miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells. 112
null 103
null 101
null 100
Anticancer activity of MDM2 inhibition in 2D and bioprinted 3D retinoblastoma cell models 98
Nutlin-3a-loaded ethosomes as a delivery system in vitro to Target p53 in melanoma 98
null 97
null 94
null 92
Multi-Step Synthesis of Chimeric Nutlin–DCA Compounds Targeting Dual Pathways for Treatment of Cancer 90
null 90
null 90
null 89
Oscillatory turbulent flow in chronic venous disease induces pro-inflammatory and reparative biological signaling 89
null 88
Perifosine plus nutlin-3 combination shows a synergistic anti-leukaemic activity. 87
null 86
null 86
MDM2 inhibitors-mediated disruption of mitochondrial metabolism: A novel therapeutic strategy for retinoblastoma 85
Nanoparticles engineered with Rituximab and loaded with Nutlin-3 show promising therapeutic activity in B leukemic xenografts 85
Use of bioactives from agrifood by-products in topical cosmetic hydrogels 85
null 84
null 83
null 81
Induction of humoral and enhanced cellular immune responses by novel core-shell nanosphere- and microsphere-based vaccine formulations following systemic and mucosal administration 74
null 74
State of the art of the therapeutic perspective of sorafenib against hematological malignancies 72
Therapeutic potential of the MDM2 inhibitor Nutlin-3 in counteracting SARS-CoV-2 infection of the eye through p53 activation 65
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines. 63
MDM2 non-genotoxic inhibitors as innovative therapeutic approaches for the treatment of pediatric malignancies 61
Selective induction of TP53I3/p53-inducible gene 3 (PIG3) in myeloid leukemic cells, but not in normal cells, by Nutlin-3 60
null 55
Totale 15.772
Categoria #
all - tutte 66.160
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.160


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022694 0 75 57 37 89 45 44 28 31 54 71 163
2022/2023767 66 48 32 91 108 98 35 66 99 32 56 36
2023/2024544 57 43 20 15 29 74 21 58 17 16 42 152
2024/20252.332 62 75 174 121 296 201 126 130 380 185 301 281
2025/20266.585 579 383 532 765 857 486 709 357 622 735 354 206
2026/2027403 179 224 0 0 0 0 0 0 0 0 0 0
Totale 15.954